DMI Pharma S.r.O

Business Development

We seek to increase the company’s profit through research and creation of new business opportunities. The assessment of the overall market as well as the derived target markets are the basis for determining new development area. To create contemporary ideas that meet the market demands:

we assess the marketing opportunities;
we define potential partnerships, customers and markets;
we support the product development process;
we design business models for partnerships ensuring mutual satisfaction;
we ensure a segment-orientated marketing approach;
we manage business intelligence of customers and competitors.

Regulatory Affairs

The Regulatory Affairs division oversees the marketing authorization procedures of the products. It supervises the safety and effectiveness of the products of the pharmaceutical industry, via ensuring them to be completely up to date with national, European and International regulations and guidelines. The regulatory executive keeps the company informed of the potential impact of any proposed changes to regulations. By working in close contact with the Marketing Area and the Area in charge of Documentation, the Regulatory Affairs division also acts as an interface between the requests of the authorities and the requirements expressed by all the company’s functional departments.

Licensing

DMI is keen on moving its dedicated efforts in collaboration with prospective partners. We value close relations that will benefit all sides and contribute to universal aim of fighting diseases. We are interested in cooperating with potential partners to make use of opportunities including those related to product licensing and acquisition, co-promotion, and product development. We are open to all those interested offering high-quality products and medical devices to new markets in Europe, CIS, Middle East.